CBD As An Antiseptic

The relationship in between infection and traditional antibiotics

Could CBD stream be useful in the fight against resistant bacterial pressures? The results from the University of Queensland in Australia suggest that it is possible. But prior to taking a look at the study in depth, it is useful to understand the development of the relationship in between germs and antibiotics.

Considering that the revolutionary discovery of penicillin by Alexander Fleming in 1928, antibiotics have actually been an essential tool in the fight against germs and infections. And although we still use the same proven approaches today, germs have actually progressed. When exposed to antibiotics, particular germs, fungis and parasites have the ability to adjust and cancel the effectiveness of the drug by developing resistance.

It’s worth pointing out that antimicrobial resistance was most likely to happen anyhow, as the genetic code for germs modifications with time. Nevertheless, it is thought that the overuse of antibiotics is an essential element that speeds up the advancement of resistant pressures.

According to the World Health Organization, antimicrobial resistance “is an increasingly major risk to international public health that requires action in all sectors of government and in society.” This has led researchers to believe outside the box by trying to recognize substances that could be helpful in the fight against harmful germs. One of these substances is cannabidiol (inner CBD), a cannabinoid discovered in Cannabis sativa.

Scientists are trying to find new ways to assault infections and resistant germs.

Dr. Mark Blaskovich, Principal Investigator and Program Coordinator for the Community for Open Antimicrobial Drug Discovery and Senior Research Officer at the Institute for Molecular Bioscience at the University of Queensland, concluded that CBD is effective against Gram-positive germs. Stress of Gram-positive germs consist of Staphylococcus aureus (typical in skin infections) and Streptococcus pneumoniae (typical in bacterial pneumonia).

Dr. Blaskovich presented his findings at an annual conference of the American Society for Microbiology. In vitro samples of both types of gram-positive germs were treated with synthetic CBD. The results led Dr. Blaskovich to the conclusion that CBD works at levels similar to those of prescription antibiotics vancomycin and daptomycin. He also discovered that CBD appeared to work against gram-positive pressures of resistant germs, which lots of traditional antibiotics are beginning to fail.

” In particular, the activity was chosen against the resistant pressures of Staphylococcus aureus (MRSA, VISA, SARV), Streptococcus pneumoniae (MDR), and Enterococcus faecalis (ERV). Cannabidiol was bactericidal, had a low propensity to cause resistance and was active against MRSA biofilms. “

The group also conducted another study utilizing topical CBD to deal with a skin infection in mice. Once again, although the results were positive, CBD did not appear to eliminate the infection, but just to minimize the number of bacterial cells.

Could CBD end up being an antibiotic?

While it is easy to hail this work as a substantial advancement in the anti-bacterial abilities of CBD, it is too soon to quit on penicillin.

Although it is thought that the effectiveness of CBD could originate from the way it assaults the biofilm surrounding bacterial cells, the authors are still uncertain of the system of action of CBD. They also did not think twice to point out the shortcomings of the study. Dr. Blaskovich explained that considering that the results remain in the initial phases, it is far too early for individuals to start treating their CBD infections themselves.

The study was also conducted in vitro (outside the body), and there is a danger that the results of clinical trials will not be the same. A number of substances have actually revealed anti-bacterial effectiveness in petri dishes, but then stopped working at this important stage. It must also be discussed that the two research studies were carried out in partnership with Botanix Pharmaceuticals Ltd, a pharmaceutical business focusing on topical CBD products.

Nevertheless, this research study could be an essential step forward for CBD and the fight against antimicrobial resistance. CBD continues to have a good safety profile and is not considered poisonous even in big amounts. Luckily, Dr. Blaskovich and his group strategy to continue their research study.

Scroll to top